Position in HLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,739,672
-$21,285,182 QoQ
Shares Held
673,294
-78.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
192,945 | $15,971,987 |
All Filings in HLN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,739,672 | 673,294 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $28,024,854 | 3,124,287 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,033,470 | 2,414,028 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,631,348 | 1,324,718 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,580,760 | 1,318,738 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,137,054 | 201,990 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,310,643 | 1,248,262 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,167,268 | 1,550,915 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,767,898 | 1,551,385 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $770,558 | 92,504 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $1,812,574 | 222,675 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $1,759,053 | 288,843 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||